Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$181.58 - $368.0 $20,700 - $41,952
-114 Closed
0 $0
Q1 2022

Apr 20, 2022

SELL
$303.87 - $423.8 $607 - $847
-2 Reduced 1.72%
114 $39,000
Q4 2021

Jan 21, 2022

BUY
$347.28 - $421.83 $694 - $843
2 Added 1.75%
116 $44,000
Q3 2021

Oct 19, 2021

SELL
$405.61 - $524.84 $811 - $1,049
-2 Reduced 1.72%
114 $46,000
Q2 2021

Jul 23, 2021

BUY
$372.84 - $481.5 $745 - $963
2 Added 1.75%
116 $55,000
Q1 2021

Apr 20, 2021

SELL
$361.28 - $504.76 $7,225 - $10,095
-20 Reduced 14.93%
114 $44,000
Q4 2020

Jan 28, 2021

SELL
$292.7 - $370.96 $2,341 - $2,967
-8 Reduced 5.63%
134 $50,000
Q3 2020

Oct 21, 2020

SELL
$268.51 - $400.74 $11,545 - $17,231
-43 Reduced 23.24%
142 $44,000
Q2 2020

Jul 31, 2020

SELL
$256.46 - $373.01 $25,645 - $37,301
-100 Reduced 35.09%
185 $69,000
Q1 2020

May 01, 2020

BUY
$209.2 - $335.53 $4,393 - $7,046
21 Added 7.95%
285 $77,000
Q4 2019

Jan 17, 2020

SELL
$288.29 - $335.49 $14,991 - $17,445
-52 Reduced 16.46%
264 $88,000
Q3 2019

Oct 11, 2019

SELL
$266.84 - $378.23 $7,471 - $10,590
-28 Reduced 8.14%
316 $96,000
Q1 2019

Apr 17, 2019

BUY
$272.57 - $321.18 $6,541 - $7,708
24 Added 7.5%
344 $107,000
Q4 2018

Jan 18, 2019

BUY
$272.46 - $366.54 $15,257 - $20,526
56 Added 21.21%
320 $96,000
Q3 2018

Oct 12, 2018

SELL
$279.04 - $367.06 $41,856 - $55,059
-150 Reduced 36.23%
264 $97,000
Q2 2018

Jul 18, 2018

SELL
$228.17 - $292.07 $10,267 - $13,143
-45 Reduced 9.8%
414 $116,000
Q1 2018

May 11, 2018

SELL
$209.54 - $253.91 $47,565 - $57,637
-227 Reduced 33.09%
459 $109,000
Q3 2017

Oct 12, 2017

BUY
$172.3 - $213.93 $118,197 - $146,755
686
686 $137,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Gemmer Asset Management LLC Portfolio

Follow Gemmer Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.